aluates Reports

$ 0.0

Automative

Global Preterm Birth Prevention and Treatment Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-5J8129

Global and United States Preterm Birth Prevention and Treatment Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Preterm Birth Prevention and Treatment Market Research Report 2025

Code: QYRE-Auto-5J8129

Report

July 2025

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AMAG Pharmaceuticals

Ferring Pharmaceutical

TEVA

Allergan plc

AbbVie

Aurobindo Pharma

Bayer

Pfizer Inc

Merck

Novartis

Sanofi

Viatris

Preterm Birth Prevention and Treatment Market Size

The global market for Preterm Birth Prevention and Treatment was valued at US$ 1499 million in the year 2024 and is projected to reach a revised size of US$ 1863 million by 2031, growing at a CAGR of 3.2% during the forecast period.

Preterm Birth Prevention and Treatment Market

Preterm birth is among the prevalent public health concerns all over the world and has become the primary cause of mortality in children aging below 5 years. To curb the alarming situation, governments including, the Food and Drug Administration (FDA), are showing immediacy in approving drugs for preterm birth prevention and management.

The preterm birth prevention and management market is driven by the increasing awareness about the adverse effects of preterm birth on neonatal health and the growing emphasis on maternal and child healthcare. Preterm birth, defined as delivery before 37 weeks of pregnancy, poses significant risks to both the baby and the mother. Advances in medical research and technology have led to the development of various interventions and treatments to prevent and manage preterm birth, such as progesterone supplements, cervical cerclage, and improved prenatal care. Additionally, rising healthcare expenditure and government initiatives aimed at reducing preterm birth rates are contributing to the market"s growth. However, challenges include the complex and multifactorial nature of preterm birth, making it difficult to predict and prevent in all cases. The effectiveness of interventions can vary depending on individual patient factors, leading to a need for personalized treatment approaches. Furthermore, access to quality healthcare and specialized facilities can be a challenge in some regions, impacting the implementation of effective preterm birth prevention and management strategies. As healthcare systems continue to evolve and research in this field progresses, the preterm birth prevention and management market is expected to witness advancements that improve maternal and neonatal outcomes.

This report aims to provide a comprehensive presentation of the global market for Preterm Birth Prevention and Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preterm Birth Prevention and Treatment.

The Preterm Birth Prevention and Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Preterm Birth Prevention and Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Preterm Birth Prevention and Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Preterm Birth Prevention and Treatment Market Report

Report Metric	Details
Report Name	Preterm Birth Prevention and Treatment Market
Accounted market size in year	US$ 1499 million
Forecasted market size in 2031	US$ 1863 million
CAGR	3.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Progesterone Therapy Corticosteroid Therapy Tocolytics Therapy Antihypertensive Therapy Magnesium Sulfate Therapy Other
Segment by Application	Hospital Drugs Stores Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AMAG Pharmaceuticals, Ferring Pharmaceutical, Teva, Allergan, AbbVie, Aurobindo Pharma, Bayer, Viatris, Pfizer, Merck & Co, Novartis, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Preterm Birth Prevention and Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Preterm Birth Prevention and Treatment Market growing?

Ans: The Preterm Birth Prevention and Treatment Market witnessing a CAGR of 3.2% during the forecast period 2025-2031.

What is the Preterm Birth Prevention and Treatment Market size in 2031?

Ans: The Preterm Birth Prevention and Treatment Market size in 2031 will be US$ 1863 million.

Who are the main players in the Preterm Birth Prevention and Treatment Market report?

Ans: The main players in the Preterm Birth Prevention and Treatment Market are AMAG Pharmaceuticals, Ferring Pharmaceutical, Teva, Allergan, AbbVie, Aurobindo Pharma, Bayer, Viatris, Pfizer, Merck & Co, Novartis, Sanofi

What are the Application segmentation covered in the Preterm Birth Prevention and Treatment Market report?

Ans: The Applications covered in the Preterm Birth Prevention and Treatment Market report are Hospital, Drugs Stores, Other

What are the Type segmentation covered in the Preterm Birth Prevention and Treatment Market report?

Ans: The Types covered in the Preterm Birth Prevention and Treatment Market report are Progesterone Therapy, Corticosteroid Therapy, Tocolytics Therapy, Antihypertensive Therapy, Magnesium Sulfate Therapy, Other

Recommended Reports

Neonatal Care Devices

Pregnancy And Fertility

Maternal And Fetal Health

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Progesterone Therapy

1.2.3 Corticosteroid Therapy

1.2.4 Tocolytics Therapy

1.2.5 Antihypertensive Therapy

1.2.6 Magnesium Sulfate Therapy

1.2.7 Other

1.3 Market by Application

1.3.1 Global Preterm Birth Prevention and Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Drugs Stores

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Preterm Birth Prevention and Treatment Market Perspective (2020-2031)

2.2 Global Preterm Birth Prevention and Treatment Growth Trends by Region

2.2.1 Global Preterm Birth Prevention and Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Preterm Birth Prevention and Treatment Historic Market Size by Region (2020-2025)

2.2.3 Preterm Birth Prevention and Treatment Forecasted Market Size by Region (2026-2031)

2.3 Preterm Birth Prevention and Treatment Market Dynamics

2.3.1 Preterm Birth Prevention and Treatment Industry Trends

2.3.2 Preterm Birth Prevention and Treatment Market Drivers

2.3.3 Preterm Birth Prevention and Treatment Market Challenges

2.3.4 Preterm Birth Prevention and Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Preterm Birth Prevention and Treatment Players by Revenue

3.1.1 Global Top Preterm Birth Prevention and Treatment Players by Revenue (2020-2025)

3.1.2 Global Preterm Birth Prevention and Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Preterm Birth Prevention and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Preterm Birth Prevention and Treatment Revenue

3.4 Global Preterm Birth Prevention and Treatment Market Concentration Ratio

3.4.1 Global Preterm Birth Prevention and Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Preterm Birth Prevention and Treatment Revenue in 2024

3.5 Global Key Players of Preterm Birth Prevention and Treatment Head office and Area Served

3.6 Global Key Players of Preterm Birth Prevention and Treatment, Product and Application

3.7 Global Key Players of Preterm Birth Prevention and Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Preterm Birth Prevention and Treatment Breakdown Data by Type

4.1 Global Preterm Birth Prevention and Treatment Historic Market Size by Type (2020-2025)

4.2 Global Preterm Birth Prevention and Treatment Forecasted Market Size by Type (2026-2031)

5 Preterm Birth Prevention and Treatment Breakdown Data by Application

5.1 Global Preterm Birth Prevention and Treatment Historic Market Size by Application (2020-2025)

5.2 Global Preterm Birth Prevention and Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Preterm Birth Prevention and Treatment Market Size (2020-2031)

6.2 North America Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Preterm Birth Prevention and Treatment Market Size by Country (2020-2025)

6.4 North America Preterm Birth Prevention and Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Preterm Birth Prevention and Treatment Market Size (2020-2031)

7.2 Europe Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Preterm Birth Prevention and Treatment Market Size by Country (2020-2025)

7.4 Europe Preterm Birth Prevention and Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Preterm Birth Prevention and Treatment Market Size (2020-2031)

8.2 Asia-Pacific Preterm Birth Prevention and Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Preterm Birth Prevention and Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Preterm Birth Prevention and Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Preterm Birth Prevention and Treatment Market Size (2020-2031)

9.2 Latin America Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Preterm Birth Prevention and Treatment Market Size by Country (2020-2025)

9.4 Latin America Preterm Birth Prevention and Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Preterm Birth Prevention and Treatment Market Size (2020-2031)

10.2 Middle East & Africa Preterm Birth Prevention and Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AMAG Pharmaceuticals

11.1.1 AMAG Pharmaceuticals Company Details

11.1.2 AMAG Pharmaceuticals Business Overview

11.1.3 AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Introduction

11.1.4 AMAG Pharmaceuticals Revenue in Preterm Birth Prevention and Treatment Business (2020-2025)

11.1.5 AMAG Pharmaceuticals Recent Development

11.2 Ferring Pharmaceutical

11.2.1 Ferring Pharmaceutical Company Details

11.2.2 Ferring Pharmaceutical Business Overview

11.2.3 Ferring Pharmaceutical Preterm Birth Prevention and Treatment Introduction

11.2.4 Ferring Pharmaceutical Revenue in Preterm Birth Prevention and Treatment Business (2020-2025)

11.2.5 Ferring Pharmaceutical Recent Development

11.3 Teva

11.3.1 Teva Company Details

11.3.2 Teva Business Overview

11.3.3 Teva Preterm Birth Prevention and Treatment Introduction

11.3.4 Teva Revenue in Preterm Birth Prevention and Treatment Business (2020-2025)

11.3.5 Teva Recent Development

11.4 Allergan

11.4.1 Allergan Company Details

11.4.2 Allergan Business Overview

11.4.3 Allergan Preterm Birth Prevention and Treatment Introduction

11.4.4 Allergan Revenue in Preterm Birth Prevention and Treatment Business (2020-2025)

11.4.5 Allergan Recent Development

11.5 AbbVie

11.5.1 AbbVie Company Details

11.5.2 AbbVie Business Overview

11.5.3 AbbVie Preterm Birth Prevention and Treatment Introduction

11.5.4 AbbVie Revenue in Preterm Birth Prevention and Treatment Business (2020-2025)

11.5.5 AbbVie Recent Development

11.6 Aurobindo Pharma

11.6.1 Aurobindo Pharma Company Details

11.6.2 Aurobindo Pharma Business Overview

11.6.3 Aurobindo Pharma Preterm Birth Prevention and Treatment Introduction

11.6.4 Aurobindo Pharma Revenue in Preterm Birth Prevention and Treatment Business (2020-2025)

11.6.5 Aurobindo Pharma Recent Development

11.7 Bayer

11.7.1 Bayer Company Details

11.7.2 Bayer Business Overview

11.7.3 Bayer Preterm Birth Prevention and Treatment Introduction

11.7.4 Bayer Revenue in Preterm Birth Prevention and Treatment Business (2020-2025)

11.7.5 Bayer Recent Development

11.8 Viatris

11.8.1 Viatris Company Details

11.8.2 Viatris Business Overview

11.8.3 Viatris Preterm Birth Prevention and Treatment Introduction

11.8.4 Viatris Revenue in Preterm Birth Prevention and Treatment Business (2020-2025)

11.8.5 Viatris Recent Development

11.9 Pfizer

11.9.1 Pfizer Company Details

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Preterm Birth Prevention and Treatment Introduction

11.9.4 Pfizer Revenue in Preterm Birth Prevention and Treatment Business (2020-2025)

11.9.5 Pfizer Recent Development

11.10 Merck & Co

11.10.1 Merck & Co Company Details

11.10.2 Merck & Co Business Overview

11.10.3 Merck & Co Preterm Birth Prevention and Treatment Introduction

11.10.4 Merck & Co Revenue in Preterm Birth Prevention and Treatment Business (2020-2025)

11.10.5 Merck & Co Recent Development

11.11 Novartis

11.11.1 Novartis Company Details

11.11.2 Novartis Business Overview

11.11.3 Novartis Preterm Birth Prevention and Treatment Introduction

11.11.4 Novartis Revenue in Preterm Birth Prevention and Treatment Business (2020-2025)

11.11.5 Novartis Recent Development

11.12 Sanofi

11.12.1 Sanofi Company Details

11.12.2 Sanofi Business Overview

11.12.3 Sanofi Preterm Birth Prevention and Treatment Introduction

11.12.4 Sanofi Revenue in Preterm Birth Prevention and Treatment Business (2020-2025)

11.12.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AMAG Pharmaceuticals

Ferring Pharmaceutical

TEVA

Allergan plc

AbbVie

Aurobindo Pharma

Bayer

Pfizer Inc

Merck

Novartis

Sanofi

Viatris

List of Tables

Table 1. Global Preterm Birth Prevention and Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Progesterone Therapy

Table 3. Key Players of Corticosteroid Therapy

Table 4. Key Players of Tocolytics Therapy

Table 5. Key Players of Antihypertensive Therapy

Table 6. Key Players of Magnesium Sulfate Therapy

Table 7. Key Players of Other

Table 8. Global Preterm Birth Prevention and Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Preterm Birth Prevention and Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Preterm Birth Prevention and Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Preterm Birth Prevention and Treatment Market Share by Region (2020-2025)

Table 12. Global Preterm Birth Prevention and Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Preterm Birth Prevention and Treatment Market Share by Region (2026-2031)

Table 14. Preterm Birth Prevention and Treatment Market Trends

Table 15. Preterm Birth Prevention and Treatment Market Drivers

Table 16. Preterm Birth Prevention and Treatment Market Challenges

Table 17. Preterm Birth Prevention and Treatment Market Restraints

Table 18. Global Preterm Birth Prevention and Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Preterm Birth Prevention and Treatment Market Share by Players (2020-2025)

Table 20. Global Top Preterm Birth Prevention and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preterm Birth Prevention and Treatment as of 2024)

Table 21. Ranking of Global Top Preterm Birth Prevention and Treatment Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Preterm Birth Prevention and Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Preterm Birth Prevention and Treatment, Headquarters and Area Served

Table 24. Global Key Players of Preterm Birth Prevention and Treatment, Product and Application

Table 25. Global Key Players of Preterm Birth Prevention and Treatment, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Preterm Birth Prevention and Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Preterm Birth Prevention and Treatment Revenue Market Share by Type (2020-2025)

Table 29. Global Preterm Birth Prevention and Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Preterm Birth Prevention and Treatment Revenue Market Share by Type (2026-2031)

Table 31. Global Preterm Birth Prevention and Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Preterm Birth Prevention and Treatment Revenue Market Share by Application (2020-2025)

Table 33. Global Preterm Birth Prevention and Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Preterm Birth Prevention and Treatment Revenue Market Share by Application (2026-2031)

Table 35. North America Preterm Birth Prevention and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Preterm Birth Prevention and Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Preterm Birth Prevention and Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Preterm Birth Prevention and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Preterm Birth Prevention and Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Preterm Birth Prevention and Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Preterm Birth Prevention and Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Preterm Birth Prevention and Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Preterm Birth Prevention and Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Preterm Birth Prevention and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Preterm Birth Prevention and Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Preterm Birth Prevention and Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Preterm Birth Prevention and Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Preterm Birth Prevention and Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 50. AMAG Pharmaceuticals Company Details

Table 51. AMAG Pharmaceuticals Business Overview

Table 52. AMAG Pharmaceuticals Preterm Birth Prevention and Treatment Product

Table 53. AMAG Pharmaceuticals Revenue in Preterm Birth Prevention and Treatment Business (2020-2025) & (US$ Million)

Table 54. AMAG Pharmaceuticals Recent Development

Table 55. Ferring Pharmaceutical Company Details

Table 56. Ferring Pharmaceutical Business Overview

Table 57. Ferring Pharmaceutical Preterm Birth Prevention and Treatment Product

Table 58. Ferring Pharmaceutical Revenue in Preterm Birth Prevention and Treatment Business (2020-2025) & (US$ Million)

Table 59. Ferring Pharmaceutical Recent Development

Table 60. Teva Company Details

Table 61. Teva Business Overview

Table 62. Teva Preterm Birth Prevention and Treatment Product

Table 63. Teva Revenue in Preterm Birth Prevention and Treatment Business (2020-2025) & (US$ Million)

Table 64. Teva Recent Development

Table 65. Allergan Company Details

Table 66. Allergan Business Overview

Table 67. Allergan Preterm Birth Prevention and Treatment Product

Table 68. Allergan Revenue in Preterm Birth Prevention and Treatment Business (2020-2025) & (US$ Million)

Table 69. Allergan Recent Development

Table 70. AbbVie Company Details

Table 71. AbbVie Business Overview

Table 72. AbbVie Preterm Birth Prevention and Treatment Product

Table 73. AbbVie Revenue in Preterm Birth Prevention and Treatment Business (2020-2025) & (US$ Million)

Table 74. AbbVie Recent Development

Table 75. Aurobindo Pharma Company Details

Table 76. Aurobindo Pharma Business Overview

Table 77. Aurobindo Pharma Preterm Birth Prevention and Treatment Product

Table 78. Aurobindo Pharma Revenue in Preterm Birth Prevention and Treatment Business (2020-2025) & (US$ Million)

Table 79. Aurobindo Pharma Recent Development

Table 80. Bayer Company Details

Table 81. Bayer Business Overview

Table 82. Bayer Preterm Birth Prevention and Treatment Product

Table 83. Bayer Revenue in Preterm Birth Prevention and Treatment Business (2020-2025) & (US$ Million)

Table 84. Bayer Recent Development

Table 85. Viatris Company Details

Table 86. Viatris Business Overview

Table 87. Viatris Preterm Birth Prevention and Treatment Product

Table 88. Viatris Revenue in Preterm Birth Prevention and Treatment Business (2020-2025) & (US$ Million)

Table 89. Viatris Recent Development

Table 90. Pfizer Company Details

Table 91. Pfizer Business Overview

Table 92. Pfizer Preterm Birth Prevention and Treatment Product

Table 93. Pfizer Revenue in Preterm Birth Prevention and Treatment Business (2020-2025) & (US$ Million)

Table 94. Pfizer Recent Development

Table 95. Merck & Co Company Details

Table 96. Merck & Co Business Overview

Table 97. Merck & Co Preterm Birth Prevention and Treatment Product

Table 98. Merck & Co Revenue in Preterm Birth Prevention and Treatment Business (2020-2025) & (US$ Million)

Table 99. Merck & Co Recent Development

Table 100. Novartis Company Details

Table 101. Novartis Business Overview

Table 102. Novartis Preterm Birth Prevention and Treatment Product

Table 103. Novartis Revenue in Preterm Birth Prevention and Treatment Business (2020-2025) & (US$ Million)

Table 104. Novartis Recent Development

Table 105. Sanofi Company Details

Table 106. Sanofi Business Overview

Table 107. Sanofi Preterm Birth Prevention and Treatment Product

Table 108. Sanofi Revenue in Preterm Birth Prevention and Treatment Business (2020-2025) & (US$ Million)

Table 109. Sanofi Recent Development

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

Table 113. Authors List of This Report

List of Figures

Figure 1. Preterm Birth Prevention and Treatment Picture

Figure 2. Global Preterm Birth Prevention and Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Preterm Birth Prevention and Treatment Market Share by Type: 2024 VS 2031

Figure 4. Progesterone Therapy Features

Figure 5. Corticosteroid Therapy Features

Figure 6. Tocolytics Therapy Features

Figure 7. Antihypertensive Therapy Features

Figure 8. Magnesium Sulfate Therapy Features

Figure 9. Other Features

Figure 10. Global Preterm Birth Prevention and Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Preterm Birth Prevention and Treatment Market Share by Application: 2024 VS 2031

Figure 12. Hospital Case Studies

Figure 13. Drugs Stores Case Studies

Figure 14. Other Case Studies

Figure 15. Preterm Birth Prevention and Treatment Report Years Considered

Figure 16. Global Preterm Birth Prevention and Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Preterm Birth Prevention and Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Preterm Birth Prevention and Treatment Market Share by Region: 2024 VS 2031

Figure 19. Global Preterm Birth Prevention and Treatment Market Share by Players in 2024

Figure 20. Global Top Preterm Birth Prevention and Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preterm Birth Prevention and Treatment as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Preterm Birth Prevention and Treatment Revenue in 2024

Figure 22. North America Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Preterm Birth Prevention and Treatment Market Share by Country (2020-2031)

Figure 24. United States Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Preterm Birth Prevention and Treatment Market Share by Country (2020-2031)

Figure 28. Germany Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Preterm Birth Prevention and Treatment Market Share by Region (2020-2031)

Figure 36. China Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Preterm Birth Prevention and Treatment Market Share by Country (2020-2031)

Figure 44. Mexico Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Preterm Birth Prevention and Treatment Market Share by Country (2020-2031)

Figure 48. Turkey Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Preterm Birth Prevention and Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. AMAG Pharmaceuticals Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2020-2025)

Figure 52. Ferring Pharmaceutical Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2020-2025)

Figure 53. Teva Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2020-2025)

Figure 54. Allergan Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2020-2025)

Figure 55. AbbVie Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2020-2025)

Figure 56. Aurobindo Pharma Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2020-2025)

Figure 57. Bayer Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2020-2025)

Figure 58. Viatris Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2020-2025)

Figure 59. Pfizer Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2020-2025)

Figure 60. Merck & Co Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2020-2025)

Figure 61. Novartis Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2020-2025)

Figure 62. Sanofi Revenue Growth Rate in Preterm Birth Prevention and Treatment Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Preterm Birth Control Market

Global Neonatal and Infantcare Products Market Insights Forecast to 2030

Preterm Birth and PROM Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neonatal and Prenatal Devices Market Insights Forecast to 2030

Bronchopulmonary Dysplasia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Baby Health Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Newborn and Prenatal Genetic Testing Market Insights Forecast to 2030

Neonatal Respiratory Distress Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Respiratory Distress Syndrome Market Insights Forecast to 2030

Neonatal Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neonatal Preterm Infants Enteral Feeding Devices Market

Global Pre pregnancy Supplements Market Insights Forecast to 2030

Global Baby Safety Product Market Research Report 2024

Global Gynecological Conditions Medications Market Research Report 2024

Preterm Birth Prevention and Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Preeclampsia Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neonatal Intensive Care Respiratory Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Baby Health Products Market Research Report 2024

Global Acute Respiratory Distress Syndrome Therapeutics Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions